NIH/NCI 1R01CA137375-01A1
(PI: Muramoto) 7/1/09 – 5/30/2014
Tobacco Cessation Training for Acupuncture, Massage, & Chiropractic Practitioners
The major purpose of this project is to address a pressing need to develop and test the effectiveness of cessation training that is grounded in guideline-based treatment and that is relevant and appropriate for CAM practitioners.
NABI Biopharmaceuticals
(PI Leischow) (12/31/09 – 1/1/11)
A Phase 3, Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Study to Assess Efficacy and
Safety of 3 aminiomethylnicotine-P aeruginosa r-Exoprotein A Conjugate Vaccine (NicVAX) as an Aid to
Smoking Cessation. Role: Co-I, Medical Director
NIH/Fogarty 1RO1TW007944-01
(PI: Nichter) (9/1/07 –8/30/12)
Cessation Research and Training in India and Indonesia
The major purpose of this project is to develop academic-community research partnerships and practice-based research networks to support tobacco cessation research in India and Indonesia. Role: Co-PI
NCI R21 CA127787
PI Muramoto (1/1/08 – 12/31/10)
Parents Awareness Reducing Exposure to Nicotine and Tobacco (PARENT)
The major purpose of this project is to develop and pilot test a system intervention for private licensed childcare centers to reduce second hand smoke exposure for children by influencing parental tobacco use.
E-mail this page